Literature DB >> 11916602

Velocity profiles in mitral blood flow based on three-dimensional freehand colour flow imaging acquired at high frame rate.

B O Haugen1, S Berg, K M Brecke, S O Samstad, S A Slørdahl, T Skjaerpe, H Torp.   

Abstract

AIMS: To describe the mitral blood flow velocity distribution, we applied a freehand dynamic three-dimensional (3D) colour flow method using a moving sample surface that followed the mitral apparatus during diastole.
METHODS: Nineteen healthy volunteers were studied. The ultrasound data were captured from 10-20 heartbeats at high frame rate (mean 46 frames/s) while freely tilting the transducer in an apical position. A magnetic position sensor system recorded the spatial position and orientation of the probe. Blood flow velocities were integrated across a spherical surface. In volumetric blood flow measurements this would yield angle independence of the Doppler beam. Raw digital data were analysed off-line with no loss of temporal resolution.
RESULTS: The ratio of the maximum velocity time integral (VTI) to the mean VTI was mean 1.3 (range 1.1-1.6). At the time of peak flow the ratio of the maximum to the mean velocity was mean 1.5 (range 1.2-2.6).
CONCLUSION: The blood flow velocity profile was non-uniform. By using a single sample volume in Doppler measurements of the maximum VTI errors ranging from 10 to 60% may be introduced in calculations of stroke volumes.

Entities:  

Mesh:

Year:  2000        PMID: 11916602     DOI: 10.1053/euje.2000.0041

Source DB:  PubMed          Journal:  Eur J Echocardiogr        ISSN: 1532-2114


  2 in total

1.  Comparative quantification of primary mitral regurgitation by computer modeling and simulated echocardiography.

Authors:  Wenbin Mao; Andrés Caballero; Rebecca T Hahn; Wei Sun
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-01-10       Impact factor: 4.733

2.  Three-Directional Evaluation of Mitral Flow in the Rat Heart by Phase-Contrast Cardiovascular Magnetic Resonance.

Authors:  Kristine Skårdal; Emil K S Espe; Lili Zhang; Jan Magnus Aronsen; Ivar Sjaastad
Journal:  PLoS One       Date:  2016-03-01       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.